Date of publication: April 30, 2021 Objectives: Evidence Summary: Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19 HTAC Recommendation Review:
High-Flow Nasal Cannula Oxygen Therapy for the Treatment of Acute Hypoxemic Respiratory Failure for COVID-19
Date of publication: December 3, 2020 Objectives: Evidence summary: High-Flow Nasal Cannula Oxygen Therapy for the Treatment of Acute Hypoxemic Respiratory Failure for COVID-19 Rapid review: High-Flow Nasal Cannula Oxygen Therapy for the Treatment of Acute Hypoxemic Respiratory Failure for COVID-19 HTAC Recommendation Preview:
Use of Pooled Testing for the Screening and Surveillance of COVID-19
Date of publication: November 20, 2020 Objectives of the Assessment: Rapid review: Use of Pooled Testing for the Diagnosis, Screening and Surveillance of COVID-19 Evidence summary: Use of Pooled Testing for the Diagnosis, Screening, and Surveillance of COVID-19 HTAC Recommendation Review:
Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19
USE OF RAPID ANTIGEN TEST KITS FOR THE DIAGNOSIS OF COVID-19 Date of publication: October 15, 2020 Objectives: Rapid review: Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19 Evidence summary: Use of Rapid Antigen Test Kits for the Diagnosis of COVID-19 Guidance document: Technical Requirements for SARS- CoV-2 Rapid Antigen Test Kits HTAC Recommendation Review:
Extracorporeal Membrane Oxygenation (ECMO) for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)
I. Assessment A. Policy and Research Question Policy Question: Should ECMO for COVID-19 patients with acute respiratory distress syndrome (ARDS) be recommended for use and covered by PhilHealth? Research Questions: Treatment guidelines and evidence synthesis on the use of ECMO Clinical efficacy / effectiveness and safety Among critically ill COVID-19 patients continue reading : Extracorporeal Membrane Oxygenation (ECMO) for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS)